LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has ...
Basilea enters agreement with Innoviva Specialty Therapeutics for commercialization of antibiotic Zevtera in US: Allschwil, Switzerland Tuesday, December 17, 2024, 15:00 Hrs [IST] ...